Allegiance Bancshares, Inc. ABTX

Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating
MT Newswires
·
Mar 7 07:13
·
Ratings
1min
Black Diamond Therapeutics
(BDTX.US)
1.680
2.370
-1.75%
+41.07%

Black Diamond Therapeutics (BDTX) has an average rating of Buy and mean price target of $14.33, according to analysts polled by FactSet.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation

please take a look The best ever Real time stock screener app With great chart ability ? : Android: https://dwz1.cc/zkNVfOg
iOS: https://dwz1.cc/gIet6Oj
The Best Stock Screener App Review So Far：
https://dwz1.cc/CjfRfWk